CDC Finds One in 400,000 Had Anaphylaxis After Moderna Shot (1)

Jan. 22, 2021, 7:14 PM UTC

About one in 400,000 recipients of the Moderna Inc. Covid-19 vaccine had a severe allergic reaction to the first shot, according to a study from the U.S. Centers for Disease Control and Prevention released on Friday.

The research, which tracked 10 cases of anaphylaxis among about 4 million doses administered through Jan. 10, concludes that such reactions to the vaccine still appear to be rare. Anaphylaxis to vaccines is uncommon but well-established -- with flu shots, for instance, it occurs about 1.3 times per million doses administered, according to CDC officials.

The CDC continues to emphasize the safety of Covid-19 ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.